Printer Friendly

WARNER-LAMBERT REPORTS RECORD SALES IN THIRD QUARTER

 WARNER-LAMBERT REPORTS RECORD SALES IN THIRD QUARTER
 MORRIS PLAINS, N.J., Oct. 20 /PRNewswire/ -- Warner-Lambert Company


(NYSE: WLA) today reported that sales for the three months ended Sept. 30, 1992, were a record for any quarter.
 Worldwide sales increased 14 percent -- 10 percent at constant currency rates -- to $1.44 billion from $1.27 billion during the third quarter of 1991. Earnings per share in the third quarter increased 14 percent to $1.22, compared with $1.07 during the same period a year earlier; and net income increased 14 percent to $165 million, compared with $144 million during the same period last year.
 Melvin R. Goodes, chairman and chief executive officer, said sales gains were led by the company's strengthening worldwide consumer business and the widespread acceptance of innovative new products. He emphasized that overall sales growth reflects the company's uniquely diversified business lines. Goodes said, "Strong top-line growth over the long term remains a strategic imperative for Warner-Lambert."
 Worldwide sales within the Pharmaceutical Sector, which includes prescription pharmaceuticals and the company's Capsugel empty hard gelatin capsule business, increased 8 percent during the third quarter.
 Warner-Lambert Reports Record Sales in Third Quarter
 Pharmaceutical Sector sales increased 23 percent in markets outside the U.S. but declined 3 percent in the U.S. compared to an extremely strong 1991 third quarter. During that period, U.S. sales increased 44 percent from the third quarter of 1990. During the most recent third quarter, Pharmaceutical Sector growth was led by the newly introduced nicotine patch Nicotrol, the cardiovascular drugs Accupril and Dilzem, the analgesic Ponstel, and Capsugel capsules. The sector also includes prescription pharmaceuticals such as Lopid, a cholesterol regulator, the anticonvulsant Dilantin and Loestrin oral contraceptives.
 During the third quarter, worldwide sales within the Consumer Sector increased by more than 17 percent. Sales rose 15 percent in the U.S. and by 21 percent outside the U.S. Driving sector growth were two new products, Cool Mint Listerine antiseptic mouthwash and Cinn-A-Burst chewing gum, as well as established brands such as Clorets gum and mints, Halls cough tablets, Schick razors and blades, and Tetra pet care products. The company's line of consumer products also includes Listerine antiseptic mouthwash, Lubriderm skin care products, Benadryl antihistamine, Rolaids antacid, Sinutab sinus medication, Tucks medicated pads, Anusol hemorrhoidal preparation, Efferdent denture cleanser, Trident sugarless gum, Bubblicious bubble gum, Certs breath mints, Dentyne chewing gum, Chiclets candy coated gum and chocolate/caramel brands including Junior Mints.
 Warner-Lambert Reports Record Sales in Third Quarter
 In important developments during the quarter, the company:
 -- introduced Nicotrol (nicotine transdermal system) in the U.S. Nicotrol is the only nicotine patch specifically designed to be worn only during waking hours.
 -- for the first time presented results of a parallel design, multicenter U.S. trial (970-26) of its experimental Alzheimer's disease drug Cognex (tacrine or THA), at the Third International Congress on Alzheimer's Disease and Related Disorders on July 17 in Padua, Italy. The data, from trials with the drug as high as 80 mg. a day, showed statistically significant outcomes on both primary measures, satisfying defined criteria for establishing efficacy.
 -- said more than 4,000 patients and 1,650 physicians are taking part in its expanded access ("treatment IND") program for Cognex in the U.S.
 Warner-Lambert is a worldwide company devoted to discovering, developing, manufacturing and marketing quality health care and consumer products. It employs approximately 34,000.
 WARNER-LAMBERT COMPANY
 Third Quarter Sales
 Three months ended Sept. 30 1992 1991
 Sales $1,438,300,000 $1,266,505,000
 Research and development 116,030,000 106,080,000
 Income before federal, state
 and foreign income taxes 222,370,000 196,998,000
 Net income 164,554,000 143,809,000
 Earnings per share $1.22 $1.07
 Average number of common
 shares outstanding 134,656,000 134,446,000
 Nine months ended Sept. 30 1992 1991
 Sales $4,123,170,000 $3,721,933,000
 Research and development 336,999,000 302,221,000
 Income before federal, state
 and foreign income taxes 683,790,000 599,863,000
 Net income before accounting
 change 506,005,000 437,900,000
 Accounting change (net of tax) -- (106,000,000)(A)
 Net income 506,005,000 331,900,000(A)
 Earnings per share $3.76 $2.47(A)
 Average number of common
 shares outstanding 134,632,000 134,403,000
 (A) -- Includes the accounting change of $146 million ($106 million after-tax or $.79 per share) reflecting the adoption of Statement of Financial Accounting Standards No. 106, "Employers' Accounting for Postretirement Benefits Other Than Pensions," recorded retroactively as of Jan. 1, 1991. Excluding the accounting change, earnings per share for six months of 1991 were $3.26.
 -0- 10/20/92
 /CONTACT: Peter Wolf, 201-540-6696, or Sandy Horner, 201-540-4268, or (investors) Stephen Mock, 201-540-6916, or Cary Rosansky, 201-540-4874, all of Warner-Lambert/
 (WLA) CO: Warner-Lambert Company ST: New Jersey IN: MTC SU: ERN


TS -- NY033 -- 2071 10/20/92 09:46 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Oct 20, 1992
Words:827
Previous Article:ABBEY HEALTHCARE REPORTS THIRD QUARTER OPERATING PROFITS UP 66 PERCENT ON 5 PERCENT REVENUE GAIN;
Next Article:BANC ONE REPORTS RECORD THIRD QUARTER AND YEAR-TO-DATE RESULTS
Topics:


Related Articles
WARNER-LAMBERT ACHIEVES RECORD SALES; RAISES DIVIDEND 16 PERCENT
WARNER-LAMBERT CEO GOODES SAYS SECOND-QUARTER SALES TO RISE BY MORE THAN 8 PERCENT
WARNER-LAMBERT REPORTS RECORD SALES AND EARNINGS IN SECOND QUARTER
WARNER-LAMBERT REPORTS THIRD-QUARTER SALES AND EARNINGS
WARNER-LAMBERT REPORTS THIRD-QUARTER SALES AND EARNINGS
Warner-Lambert Reports Third Quarter Results
Warner-Lambert Reports Fourth Quarter, Full-Year Sales And Earnings
Warner-Lambert Reports First Quarter Sales and Earnings
Warner-Lambert Reports Second Quarter Gain of 8% EPS on Sales Increase of 10%
Warner-Lambert Reports Record Fourth Quarter Sales And Record Sales And Earnings For 1997

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters